Can a smart monitor help control diabetes? new study tests CGM in community clinics

NCT ID NCT07097415

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tested whether using a continuous glucose monitor (CGM) helps adults with type 2 diabetes control their blood sugar better than traditional finger-prick testing. About 600 participants from two community health centers in China wore a CGM device for three 2-week periods over 24 weeks. The main goal was to see if their HbA1c levels improved. The study also looked at how easy or hard it is to use CGM in everyday community care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitoring (CGM) device
What this could lead to
If successful, this could show that CGM helps people with type 2 diabetes better manage their blood sugar and improve quality of life in community settings.
What could go wrong
This is a completed pragmatic trial with 599 participants, but results may not apply to all populations. CGM devices can be costly and require training, and the study does not test a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuming Street Community Health Service Center

    Ningbo, China

  • Qianhu Hospital

    Ningbo, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.